Home » Markets » Johnson & Johnson coronavirus vaccine could scale up to a billion doses by end of 2021: CEO
Johnson & Johnson coronavirus vaccine could scale up to a billion doses by end of 2021: CEO
Johnson & Johnson CEO: Coronavirus vaccine early testing is ‘quite encouraging’
Johnson & Johnson CEO Alex Gorsky discusses the development of a coronavirus vaccine and other medical developments in the works.
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here
Continue Reading Below
Johnson & Johnson has narrowed down a lead coronavirus vaccine candidate to test on humans and wants to scale up to nearly one billion doses of the vaccine by the end of 2021 if it proves effective and safe, CEO Alex Gorsky told "Mornings with Maria" on Tuesday.
"This would ordinarily take about five years, but as we all know these are very different times," Gorsky said. "We've got a team of scientists literally working around the clock since January."